A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).

H Yano; N Kitano; M Morimoto; K S Polonsky; H Imura; Y Seino

doi:10.1172/JCI115795

A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).

H Yano, N Kitano, M Morimoto, K S Polonsky, H Imura, and Y Seino

Published June 1, 1992 - More info

View PDF

Abstract

We have identified a 65-yr-old nonobese Japanese man with diabetes mellitus, fasting hyperinsulinemia (150-300 pM), and a reduced fasting C-peptide/insulin molar ratio of 2.5-3.0. Fasting hyperinsulinemia was also found in his son and daughter. Analysis of insulin isolated from the serum of the proband and his son by reverse-phase high performance liquid chromatography revealed a minor peak coeluting with human insulin and a major peak of proinsulin-like materials. The insulin gene of the patient was amplified by the polymerase chain reaction and the products were sequenced. A novel point mutation was identified in which guanine was replaced by thymine. The substitution gives rise to a new HindIII recognition site and results in the amino acid replacement of leucine for arginine at position 65. These results indicate that the amino-acid replacement prevents recognition of the C-peptide-A chain dibasic protease and results in an elevation of proinsulin-like materials in the circulation. Furthermore, in this family the proinsulin-like materials is due to a biosynthetic defect, inherited as an autosomal dominant trait. Rapid detection of this mutation can be accomplished by HindIII restriction enzyme mapping of polymerase chain reaction-generated DNA, which enables us to facilitate the diagnosis and screening.

Images.